# FDA Inspection 1198165 - Amir Moradi MD - February 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/amir-moradi-md/15010f87-0a06-4f9e-ba1e-1bc15fda9bd2
Source feed: FDA_Inspections

> FDA Inspection 1198165 for Amir Moradi MD on February 10, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198165
- Company Name: Amir Moradi MD
- Inspection Date: 2023-02-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1285252 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/amir-moradi-md/0ac55744-aa46-446d-a547-9027dda23d8b)
- [FDA Inspection 1285252 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/amir-moradi-md/14597ba7-ef40-4d00-aad2-3c32329ed52e)
- [FDA Inspection 1035283 - 2017-11-29](https://www.keypedia.com/records/fda_inspections/amir-moradi-md/ea5c766d-6ffd-4888-8151-8e55f9c3b2a3)
- [FDA Inspection 914405 - 2015-02-11](https://www.keypedia.com/records/fda_inspections/amir-moradi-md/6ae9dbbb-2d2b-4460-95c5-199a21f6708b)

Company: https://www.keypedia.com/companies/amir-moradi-md/233e189e-0fb9-44c0-a8ca-a45b50fb76cb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c